More women with breast cancer will be switched from tamoxifen to one of the aromatase inhibitors

More women with breast cancer will be switched from tamoxifen to one of the aromatase inhibitors... Arimidex, Femara, or Aromasin.

These drugs seem more effective for preventing recurrence in postmenopausal women with estrogen-receptor positive breast cancer.

Tamoxifen blocks estrogen receptors...but tumors can become resistant to its effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote